Avaliação do perfil evolutivo da retocolite ulcerativa em ambulatório de referência brasileiro para doenças intestinais, no período de 20 anos

Detalhes bibliográficos
Ano de defesa: 2016
Autor(a) principal: Ricardo Pereira Mendes
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Minas Gerais
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: https://hdl.handle.net/1843/BUOS-AQBRBZ
Resumo: Ulcerative colitis (UC) is characterized by recurring episodes of inflammation limited to the mucosal layer of the colon. Although the disease can be potentially curative with proctocolectomy, medical therapies are the mainstay of treatment. The aim of the study was to evaluate the behavior of UC over 20 years from an InflammatoryBowel Disease Referral Center in Brazil. A longitudinal retrospective analysis of 101 patients with UC was conducted. The characteristics of patients and their diseases were described, and the cumulative probabilities of receiving medical therapies were assessed using the Kaplan-Meier method. Median age at diagnosis was 34 years, with a female preponderance. 14% of patients had proctitis, 42% leftsidedand 40% extensive colitis. Cumulative probabilities of receveing 5-aminosalicylic acid at 1 year and 10 years were 78% and 90%, respectively. Cumulative probabilities of receiveing immunosuppressants at 1 year and 10 years were 15% and 59%, respectively. There was, over the years, a trend of reduction in the need for corticosteroid therapy. In the year of diagnosis, 62.1% of patients used corticosteroids and, in the tenth year, this rate was 28.3%. It was concluded that some epidemiological data differ from the literature, as higher female prevalence and higher percentage of extensive colitis at the diagnosis. It was observed thatmost patients required immunosuppressants to achieve clinical remission. Patients older than 50 years at diagnosis had less need to initiate immunosuppressive therapy, and its use wasnt associated with the extent of the disease.
id UFMG_f43ffb4e57403bf38fae673f900b237e
oai_identifier_str oai:repositorio.ufmg.br:1843/BUOS-AQBRBZ
network_acronym_str UFMG
network_name_str Repositório Institucional da UFMG
repository_id_str
spelling Avaliação do perfil evolutivo da retocolite ulcerativa em ambulatório de referência brasileiro para doenças intestinais, no período de 20 anosIntestino grossoMedicinaDoenças Inflamatórias IntestinaisProctocoliteRetocolite ulcerativaIntestino grossoDoença InflamatóriaIntestinalUlcerative colitis (UC) is characterized by recurring episodes of inflammation limited to the mucosal layer of the colon. Although the disease can be potentially curative with proctocolectomy, medical therapies are the mainstay of treatment. The aim of the study was to evaluate the behavior of UC over 20 years from an InflammatoryBowel Disease Referral Center in Brazil. A longitudinal retrospective analysis of 101 patients with UC was conducted. The characteristics of patients and their diseases were described, and the cumulative probabilities of receiving medical therapies were assessed using the Kaplan-Meier method. Median age at diagnosis was 34 years, with a female preponderance. 14% of patients had proctitis, 42% leftsidedand 40% extensive colitis. Cumulative probabilities of receveing 5-aminosalicylic acid at 1 year and 10 years were 78% and 90%, respectively. Cumulative probabilities of receiveing immunosuppressants at 1 year and 10 years were 15% and 59%, respectively. There was, over the years, a trend of reduction in the need for corticosteroid therapy. In the year of diagnosis, 62.1% of patients used corticosteroids and, in the tenth year, this rate was 28.3%. It was concluded that some epidemiological data differ from the literature, as higher female prevalence and higher percentage of extensive colitis at the diagnosis. It was observed thatmost patients required immunosuppressants to achieve clinical remission. Patients older than 50 years at diagnosis had less need to initiate immunosuppressive therapy, and its use wasnt associated with the extent of the disease.Universidade Federal de Minas Gerais2019-08-12T01:17:36Z2025-09-09T00:15:11Z2019-08-12T01:17:36Z2016-12-16info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttps://hdl.handle.net/1843/BUOS-AQBRBZRicardo Pereira Mendesinfo:eu-repo/semantics/openAccessporreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMG2025-09-09T00:15:11Zoai:repositorio.ufmg.br:1843/BUOS-AQBRBZRepositório InstitucionalPUBhttps://repositorio.ufmg.br/oairepositorio@ufmg.bropendoar:2025-09-09T00:15:11Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false
dc.title.none.fl_str_mv Avaliação do perfil evolutivo da retocolite ulcerativa em ambulatório de referência brasileiro para doenças intestinais, no período de 20 anos
title Avaliação do perfil evolutivo da retocolite ulcerativa em ambulatório de referência brasileiro para doenças intestinais, no período de 20 anos
spellingShingle Avaliação do perfil evolutivo da retocolite ulcerativa em ambulatório de referência brasileiro para doenças intestinais, no período de 20 anos
Ricardo Pereira Mendes
Intestino grosso
Medicina
Doenças Inflamatórias Intestinais
Proctocolite
Retocolite ulcerativa
Intestino grosso
Doença Inflamatória
Intestinal
title_short Avaliação do perfil evolutivo da retocolite ulcerativa em ambulatório de referência brasileiro para doenças intestinais, no período de 20 anos
title_full Avaliação do perfil evolutivo da retocolite ulcerativa em ambulatório de referência brasileiro para doenças intestinais, no período de 20 anos
title_fullStr Avaliação do perfil evolutivo da retocolite ulcerativa em ambulatório de referência brasileiro para doenças intestinais, no período de 20 anos
title_full_unstemmed Avaliação do perfil evolutivo da retocolite ulcerativa em ambulatório de referência brasileiro para doenças intestinais, no período de 20 anos
title_sort Avaliação do perfil evolutivo da retocolite ulcerativa em ambulatório de referência brasileiro para doenças intestinais, no período de 20 anos
author Ricardo Pereira Mendes
author_facet Ricardo Pereira Mendes
author_role author
dc.contributor.author.fl_str_mv Ricardo Pereira Mendes
dc.subject.por.fl_str_mv Intestino grosso
Medicina
Doenças Inflamatórias Intestinais
Proctocolite
Retocolite ulcerativa
Intestino grosso
Doença Inflamatória
Intestinal
topic Intestino grosso
Medicina
Doenças Inflamatórias Intestinais
Proctocolite
Retocolite ulcerativa
Intestino grosso
Doença Inflamatória
Intestinal
description Ulcerative colitis (UC) is characterized by recurring episodes of inflammation limited to the mucosal layer of the colon. Although the disease can be potentially curative with proctocolectomy, medical therapies are the mainstay of treatment. The aim of the study was to evaluate the behavior of UC over 20 years from an InflammatoryBowel Disease Referral Center in Brazil. A longitudinal retrospective analysis of 101 patients with UC was conducted. The characteristics of patients and their diseases were described, and the cumulative probabilities of receiving medical therapies were assessed using the Kaplan-Meier method. Median age at diagnosis was 34 years, with a female preponderance. 14% of patients had proctitis, 42% leftsidedand 40% extensive colitis. Cumulative probabilities of receveing 5-aminosalicylic acid at 1 year and 10 years were 78% and 90%, respectively. Cumulative probabilities of receiveing immunosuppressants at 1 year and 10 years were 15% and 59%, respectively. There was, over the years, a trend of reduction in the need for corticosteroid therapy. In the year of diagnosis, 62.1% of patients used corticosteroids and, in the tenth year, this rate was 28.3%. It was concluded that some epidemiological data differ from the literature, as higher female prevalence and higher percentage of extensive colitis at the diagnosis. It was observed thatmost patients required immunosuppressants to achieve clinical remission. Patients older than 50 years at diagnosis had less need to initiate immunosuppressive therapy, and its use wasnt associated with the extent of the disease.
publishDate 2016
dc.date.none.fl_str_mv 2016-12-16
2019-08-12T01:17:36Z
2019-08-12T01:17:36Z
2025-09-09T00:15:11Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/1843/BUOS-AQBRBZ
url https://hdl.handle.net/1843/BUOS-AQBRBZ
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Minas Gerais
publisher.none.fl_str_mv Universidade Federal de Minas Gerais
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFMG
instname:Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
instname_str Universidade Federal de Minas Gerais (UFMG)
instacron_str UFMG
institution UFMG
reponame_str Repositório Institucional da UFMG
collection Repositório Institucional da UFMG
repository.name.fl_str_mv Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)
repository.mail.fl_str_mv repositorio@ufmg.br
_version_ 1879513148936945664